This opportunity is no longer accepting applications.
grant PAR-24-049

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

This funding opportunity supports research necessary to plan Phase II-IV clinical trials related to heart, lung, blood, and sleep disorders. It aims to ensure that the studies proposed (R34) provide essential information to design and plan future trials without needing additional studies. The research should focus on testing the efficacy, safety, clinical management, or implementation of inter…

This Notice of Funding Opportunity Announcement (NOFO) intends to supports studies that are both necessary and sufficient to inform the planning of a Phase II-IV clinical trial within NHLBI's mission. The NHLBI expects that applications to this NOFO will describe the planned clinical trial and i…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Heart, Lung, and Blood Institute
Program: SBIR

Dates

Opportunity Released: November 3, 2023
Open for Submission: November 3, 2023
Submission Deadline: January 7, 2027
Application Window Closes: January 7, 2027

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.